Russell Investments »

Sarepta Therapeutics Inc Note 1.250 9/1 shares owned by Russell Investments

Quarter-by-quarter ownership of Sarepta Therapeutics Inc Note 1.250 9/1 shares owned by Russell Investments from 13F filings

Historical chart of Russell Investments investment in Sarepta Therapeutics Inc Note 1.250 9/1

Tip: Access up to 7 years of quarterly data

All positions including Sarepta Therapeutics Inc Note 1.250 9/1 held by Russell Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sarepta Therapeutics Inc Note 1.250 9/1 by Russell Investments

Quarter filed Position value Share count Share price at filing
2024-03-31 $447k 382k 1.17
2023-12-31 $459k 451k 1.02
2023-09-30 $577k 514k 1.12

More positions owned by Russell Investments

Microsoft Corp Common Stock (MSFT)
Nvidia Corp Common Stock (NVDA)
Apple Common Stock (AAPL)
Amazon Common Stock (AMZN)
Meta Platforms Common Stock (META)
Alphabet Common Stock (GOOGL)
Alphabet Common Stock (GOOG)
Taiwan Semiconductor Manufacturing Common Stock (TSM)
Mastercard Incorporated Common Stock (MA)
Prologis Common Stock (PLD)
Unitedhealth Group Common Stock (UNH)
Eli Lilly And Company Common Stock (LLY)
Equinix Common Stock (EQIX)
Welltower Common Stock (WELL)
Visa Common Stock (V)

View all positions for Russell Investments

Top funds holding Sarepta Therapeutics Inc Note 1.250 9/1

Wolverine Asset Management
Calamos Advisors
Braidwell
Highbridge Capital Management
Davidson Kempner Capital Management
Readystate Asset Management
Bank of America Corporation
Lazard Asset Management
Tenor Capital Management
D. E. Shaw & Co
Bank Of Montreal
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
Steelhead Partners
Capstone Investment Advisors
Weiss Asset Management LP[1

View all funds holding Sarepta Therapeutics Inc Note 1.250 9/1